4 Midcap Rising Quarterly Revenue Run Rate Stocks to Watch for Future Multibagger Potential: Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis
- October 29, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Max Healthcare Rs 851.50. Waaree Energies Rs 2,238. Kalyan Jewellers Rs 510. Mphasis Rs 2,518. Market caps from Rs 47,225 crore to Rs 86,925 crore. Data as of 28 Oct 2026.
Quick Answer
Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis are the 4 picks in this rising quarterly revenue run rate stocks watchlist, with market caps between Rs 47,225 crore and Rs 86,925 crore. Max Healthcare stands out for the largest market cap at Rs 86,925 crore, while Waaree Energies offers the highest return on equity at 25.71%. PE ratios run from 16.90 to 59.66, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.
Rising quarterly revenue run rate stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis meet that test, with market caps from Rs 47,225 crore to Rs 86,925 crore and Max Healthcare offering the largest market cap at Rs 86,925 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a latest quarter revenue that, multiplied by four, is at least 10 per cent above the FY26 revenue, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a latest quarter revenue that, multiplied by four, is at least 10 per cent above the FY26 revenue, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening rising quarterly revenue run rate stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Rising Quarterly Revenue Run Rate Stocks and Why Do They Attract Multibagger Interest?
Rising quarterly revenue run rate stocks are shares of mid sized companies whose latest quarterly sales, if repeated for four quarters, would be well above the revenue of the full financial year, a sign that the business is scaling up. The four here cover solar energy, jewellery, IT services and hospitals.
A quarter that sells at a faster pace than the full year points to rising demand and a bigger base for the year ahead, and rising profit shows that the extra sales are paying off. For rising quarterly revenue run rate stocks, both FY26 and the latest quarter showed growth. Whichever way you read rising quarterly revenue run rate stocks, the common thread is rising profit backed by complete financial data. A sensible way to study rising quarterly revenue run rate stocks is to look at profit growth, returns and valuation side by side. Below, each of rising quarterly revenue run rate stocks gets its own breakdown of growth, returns and valuation. Treat rising quarterly revenue run rate stocks as a research list, since share prices and rankings change with every earnings season.
Rising Quarterly Revenue Run Rate Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 28 October 2026. Waaree Energies combines the lowest PE of the group, 16.90, with the highest return on equity, 25.71%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Max Healthcare Institute | 851.50 | 86,925 | 59.66 | 60.75 | 13.42% | 0.32 | 815.00 to 1,221.90 |
| Waaree Energies | 2,238 | 67,650 | 16.90 | 45.89 | 25.71% | 0.22 | 2,238.00 to 3,718.80 |
| Kalyan Jewellers India | 510 | 53,299 | 37.16 | 46.75 | 21.41% | 0.97 | 327.05 to 648.95 |
| Mphasis | 2,518 | 47,225 | 24.72 | 18.49 | 17.34% | 0.24 | 2,013.00 to 2,975.00 |
Max Healthcare: 24.26% Profit CAGR Since FY22
Max Healthcare Institute runs a network of multi-speciality hospitals in Delhi NCR, Mumbai and other cities. It reported FY26 revenue of Rs 8,536.07 crore, up 18.82% year on year, and net profit of Rs 1,442.41 crore, up 34.07%. Net profit has compounded at 24.26% a year since FY22, while revenue has grown 20.42% a year. Operating margin was 28.15% in FY26. The debt-to-equity ratio is 0.32.
In the June 2026 quarter, revenue rose 16.60% to Rs 2,406.69 crore and net profit grew 4.87% to Rs 322.96 crore. The share price has gained 149.91% over five years. Domestic institutions raised their holding from 17.42% in June 2025 to 29.96% in June 2026. The stock trades at a PE of 59.66 against an industry PE of 60.75, below the sector average, with a return on equity of 13.42%.
Waaree Energies: Revenue Up 83.52% in FY26
Waaree Energies is one of India’s largest solar module makers by capacity and manufactures solar cells and modules. It reported FY26 revenue of Rs 27,244.92 crore, up 83.52% year on year, and net profit of Rs 3,884.15 crore, up 101.45%. Revenue has compounded at 74.31% a year since FY22. Operating margin was 23.82% in FY26. The debt-to-equity ratio is 0.22.
The stock trades at a PE of 16.90 against an industry PE of 45.89, below the sector average, with a return on equity of 25.71%. In the June 2026 quarter, revenue rose 76.25% to Rs 8,102.60 crore and net profit grew 15.39% to Rs 891.87 crore. Domestic institutions raised their holding from 2.82% in September 2025 to 4.09% in September 2026.
Kalyan Jewellers: 56.69% Profit CAGR Since FY22
Kalyan Jewellers is one of the largest jewellery retailers in India, with showrooms across India and the Middle East. It reported FY26 revenue of Rs 35,950.88 crore, up 42.72% year on year, and net profit of Rs 1,350.39 crore, up 89.09%. Net profit has compounded at 56.69% a year since FY22, while revenue has grown 34.90% a year. Operating margin was 7.62% in FY26.
In the June 2026 quarter, revenue rose 45.52% to Rs 10,644.67 crore and net profit grew 32.03% to Rs 348.67 crore. The share price has gained 618.28% over five years and 14.90% over the past year. Promoters hold 62.85%, which keeps ownership stable. The stock trades at a PE of 37.16 against an industry PE of 46.75, below the sector average, with a return on equity of 21.41%.
Mphasis: Profit Compounding at 6.81% a Year
Mphasis provides IT, cloud and application services to banking, insurance and technology clients. It reported FY26 revenue of Rs 16,205.54 crore, up 11.88% year on year, and net profit of Rs 1,862.60 crore, up 9.43%. Net profit has compounded at 6.81% a year since FY22, while revenue has grown 7.53% a year. Operating margin was 20.58% in FY26. The debt-to-equity ratio is 0.24.
The stock trades at a PE of 24.72 against an industry PE of 18.49, with a return on equity of 17.34%. The dividend yield is 2.50%. In the June 2026 quarter, revenue rose 17.14% to Rs 4,466.91 crore and net profit grew 10.82% to Rs 489.51 crore. Domestic institutions raised their holding from 37.07% in September 2025 to 45.85% in September 2026.
Rising Quarterly Revenue Run Rate Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these rising quarterly revenue run rate stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | Latest Quarter Revenue Growth | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Max Healthcare | 8,536.07 | 1,442.41 | 18.82% | 20.42% | 16.60% | 27.00% |
| Waaree Energies | 27,244.92 | 3,884.15 | 83.52% | 74.31% | 76.25% | 20.31% |
| Kalyan Jewellers | 35,950.88 | 1,350.39 | 42.72% | 34.90% | 45.52% | 6.50% |
| Mphasis | 16,205.54 | 1,862.60 | 11.88% | 7.53% | 17.14% | 20.04% |
Check the Univest Screener for live data on these rising quarterly revenue run rate stocks
Institutional Holding in Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis
Institutional holding shows who is backing these rising quarterly revenue run rate stocks alongside the promoter. The table uses the latest reported quarter for each. Max Healthcare has the deepest institutional backing, with FII and DII together holding 71.74% as of June 2026. Domestic institutions increased their holding over the past year in Max Healthcare (from 17.42% to 29.96%), Waaree Energies (from 2.82% to 4.09%) and Mphasis (from 37.07% to 45.85%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Max Healthcare | 23.71% | 41.78% | 29.96% | 4.56% | June 2026 |
| Waaree Energies | 64.12% | 8.57% | 4.09% | 23.22% | September 2026 |
| Kalyan Jewellers | 62.85% | 13.83% | 14.41% | 8.91% | September 2026 |
| Mphasis | 30.53% | 19.39% | 45.85% | 4.23% | September 2026 |
Risks to Weigh in Rising Quarterly Revenue Run Rate Stocks
Being careful with rising quarterly revenue run rate stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Mphasis trades at a PE of 24.72 against an industry PE of 18.49, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Rising Quarterly Revenue Run Rate Stocks
Picking from rising quarterly revenue run rate stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (18.49 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis live prices.
Conclusion
Among rising quarterly revenue run rate stocks, Max Healthcare stands out for the largest market cap at Rs 86,925 crore, Waaree Energies for the highest return on equity at 25.71%, Kalyan Jewellers for the fastest profit growth, 56.69% a year since FY22 and Mphasis for 11.88% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing rising quarterly revenue run rate stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Rising Quarterly Revenue Run Rate Stocks to Watch
Which are the best rising quarterly revenue run rate stocks to watch for multibagger potential?
Ans. Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis are the 4 names this list highlights, with market caps of Rs 86,925 crore, Rs 67,650 crore, Rs 53,299 crore and Rs 47,225 crore respectively. Max Healthcare is notable for the largest market cap at Rs 86,925 crore. Waaree Energies stands out for the highest return on equity at 25.71%. Kalyan Jewellers offers the fastest profit growth, 56.69% a year since FY22. Mphasis brings 11.88% revenue growth in FY26. These are watchlist names for rising quarterly revenue run rate stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Waaree Energies a good stock for long-term investors?
Ans. Waaree Energies has a return on equity of 25.71%, a PE of 16.90 against an industry PE of 45.89 and a market cap of Rs 67,650 crore. FY26 revenue rose 83.52%, and June 2026 quarter net profit grew 15.39%. Long-term returns in rising quarterly revenue run rate stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Kalyan Jewellers become a multibagger from here?
Ans. Kalyan Jewellers has already gained 618.28% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in rising quarterly revenue run rate stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 56.69% a year since FY22, and FY26 revenue rose 42.72%. At a PE of 37.16 against an industry PE of 46.75, valuation should be checked against that growth before investing.
What is the market cap of Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis?
Ans. As of 28 October 2026, Max Healthcare has a market cap of Rs 86,925 crore, Waaree Energies has a market cap of Rs 67,650 crore, Kalyan Jewellers has a market cap of Rs 53,299 crore and Mphasis has a market cap of Rs 47,225 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on rising quarterly revenue run rate stocks.
What are the risks of investing in rising quarterly revenue run rate stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Mphasis trades at a PE of 24.72 against an industry PE of 18.49, so earnings growth needs to hold up.
Why is Mphasis trading at a PE of 24.72?
Ans. Mphasis’ PE of 24.72 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 17.34% and latest-quarter profit growth of 10.82%, which also means the stock is more sensitive if growth slows. Investors in rising quarterly revenue run rate stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Max Healthcare, Waaree Energies, Kalyan Jewellers and Mphasis?
Ans. As of the latest reported quarter, FII and DII together hold 71.74% of Max Healthcare (41.78% and 29.96%), 12.66% of Waaree Energies (8.57% and 4.09%), 28.24% of Kalyan Jewellers (13.83% and 14.41%) and 65.24% of Mphasis (19.39% and 45.85%). Rising institutional holding is a useful signal in rising quarterly revenue run rate stocks, though it should be read with earnings trends rather than on its own.
